Sale!

CLCN2 Gene Epilepsy Idiopathic Generalized Type 11 Genetic Test

Original price was: $700.Current price is: $500.

-29%

The CLCN2 Gene Epilepsy Idiopathic Generalized Type 11 NGS Genetic DNA Test is a cutting-edge genetic analysis that identifies mutations in the CLCN2 gene associated with idiopathic generalized epilepsy type 11. This comprehensive test utilizes Next Generation Sequencing (NGS) technology to provide precise genetic information crucial for accurate diagnosis and personalized treatment planning. The test is particularly valuable for individuals experiencing unexplained seizures, those with family history of epilepsy, or patients with treatment-resistant seizure disorders. Results are typically available within 3-4 weeks and require either blood sample, extracted DNA, or one drop of blood on FTA card. The test is priced at $500 USD and includes pre-test genetic counseling to ensure proper understanding and interpretation of results.

Trusted Testing. Expert Care. Guaranteed Privacy.

  • Accredited and Trusted
  • Expert Scientists, Advanced Technology
  • Data Privacy Guaranteed
Guaranteed Safe Checkout

CLCN2 Gene Epilepsy Idiopathic Generalized Type 11 NGS Genetic DNA Test

Understanding CLCN2 Gene Epilepsy Testing

The CLCN2 Gene Epilepsy Idiopathic Generalized Type 11 NGS Genetic DNA Test represents a breakthrough in neurological genetic diagnostics. This advanced test specifically targets mutations in the CLCN2 gene, which encodes the chloride channel protein CLC-2. Disruptions in this gene have been scientifically linked to idiopathic generalized epilepsy type 11, a hereditary form of epilepsy characterized by various seizure types without identifiable structural brain abnormalities.

What Does This Test Measure?

This comprehensive genetic analysis utilizes Next Generation Sequencing (NGS) technology to examine the complete coding region of the CLCN2 gene. The test detects:

  • Point mutations and single nucleotide variants
  • Small insertions and deletions
  • Copy number variations affecting the CLCN2 gene
  • Pathogenic variants associated with epilepsy susceptibility

Who Should Consider This Test?

This genetic test is particularly recommended for individuals experiencing:

  • Unexplained recurrent seizures or convulsions
  • Family history of epilepsy or seizure disorders
  • Treatment-resistant epilepsy cases
  • Generalized tonic-clonic seizures without clear cause
  • Absence seizures or myoclonic jerks
  • Early-onset epilepsy symptoms

Clinical Indications and Symptoms

Patients presenting with symptoms such as sudden loss of consciousness, involuntary muscle contractions, staring spells, or unexplained neurological episodes should consider this test. Early genetic diagnosis can significantly impact treatment outcomes and family planning decisions.

Benefits of CLCN2 Genetic Testing

  • Accurate Diagnosis: Provides definitive genetic confirmation of epilepsy type
  • Personalized Treatment: Enables targeted anti-epileptic medication selection
  • Family Planning: Offers genetic counseling for inheritance risk assessment
  • Prognostic Information: Helps predict disease course and potential complications
  • Early Intervention: Facilitates timely management strategies
  • Research Contribution: Advances understanding of genetic epilepsy mechanisms

Understanding Your Test Results

Your genetic test results will be carefully interpreted by our team of certified genetic counselors and neurologists. Results typically fall into three categories:

Positive Result

A positive result indicates the presence of a pathogenic mutation in the CLCN2 gene. This confirms the genetic basis of your epilepsy and provides valuable information for treatment planning and family risk assessment.

Negative Result

A negative result means no disease-causing mutations were detected in the CLCN2 gene. However, this doesn’t completely rule out genetic epilepsy, as other genes may be involved.

Variant of Uncertain Significance

Some genetic changes may be identified whose clinical significance is currently unknown. These variants require ongoing monitoring and may be reclassified as more research becomes available.

Test Details and Pricing

Test Component Details
Test Name CLCN2 Gene Epilepsy Idiopathic Generalized Type 11 NGS Genetic DNA Test
Regular Price $700 USD
Discount Price $500 USD
Turnaround Time 3 to 4 Weeks
Sample Type Blood, Extracted DNA, or One Drop Blood on FTA Card
Testing Method Next Generation Sequencing (NGS)

Pre-Test Requirements

Before undergoing testing, patients must provide:

  • Complete clinical history relevant to epilepsy symptoms
  • Participation in genetic counseling session
  • Family pedigree chart documenting affected relatives
  • Informed consent for genetic testing

Nationwide Testing Availability

We proudly offer this advanced genetic testing service across the United States with convenient locations in all major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, and San Jose. Our state-of-the-art laboratories ensure consistent, high-quality results regardless of your location.

Take Control of Your Neurological Health

Understanding the genetic basis of epilepsy can transform your treatment journey and provide clarity for your entire family. Our team of neurological genetics specialists is ready to guide you through every step of the testing process, from initial consultation to result interpretation and ongoing management.

Ready to begin your genetic testing journey? Contact our genetic counseling team today at +1(267) 388-9828 or schedule your appointment online. Take the first step toward personalized epilepsy management and genetic clarity.